✦ LIBER ✦

Combination endocrine therapy in breast cancer

✍ Scribed by Stoll, Basil A

Book ID: 122949120
Publisher: Elsevier Science
Year: 1985
Weight: 478 KB
Volume: 21
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(85)90029-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials update: endocrine and bi

Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer

✍ Alexandra F Leary, Bhawna Sirohi, Stephen RD Johnston 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 82 KB

Endocrine effects of combined somatostat

Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer

✍ Andrea Manni; Alice E. Boucher; Laurence M. Demers; Harold A. Harvey; Allan Lipt 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 752 KB

Therapeutic Resistance to Anti-Hormonal

Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer || Endocrine Resistance in Breast Cancer- Where Are We NowWith Intelligent Combination Therapies?

✍ Hiscox, Stephen; Gee, Julia; Nicholson, Robert I. 📂 Article 📅 2009 🏛 Springer Netherlands ⚖ 292 KB

Chemotherapy versus combination of chemo

Chemotherapy versus combination of chemotherapy and endocrine therapy in advanced breast cancer: A prospective randomized study

✍ G. Cocconi; V. de Lisi; C. Boni; P. Mori; P. Malacarne; D. Amadori; E. Giovanell 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 691 KB

Endocrine effects of combination antioes

Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancer

✍ Walker, Kerry J.; Walker, Richard F.; Turkes, Atilla; Robertson, John F.R.; Blam 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 470 KB

Combined endocrine effects of LHRH agoni

Combined endocrine effects of LHRH agonist (Zoladex®) and tamoxifen (Nolvadex®) therapy in premenopausal women with breast cancer

✍ Mr J. F. R. Robertson; K. J. Walker; R. I. Nicholson; R. W. Blamey 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB 👁 2 views

Abstract In premenopausal women with breast cancer, the use of the luteinizing hormone releasing hormone agonist, goserelin, results in the production of serum levels of oestradiol equivalent to those after surgical oöphorectomy or in postmenopausal women. The standard first line hormonal treatment